Research Article

Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats

Figure 3

Electromyography amplitude on day 21 posttreatment. The injured group showed a significant decrease in EMG amplitude compared to the sham group. All treated groups showed an increase in EMG amplitude ( vs. sham, #injured, @adipose tissue-derived mesenchymal stem cells (ADMSCs), ^pregabalin, or $combined). The combined treatment showed a significant improvement in EMG amplitude compared to pregabalin (), but not to ADMSCs alone ().